In situfabrication of Cu-Mn-O nanostructure catalysts on Ti mesh and their catalytic property optimization for low-temperature and stable CO oxidation.

A series of interlaced 'tripe-shaped' nanoflake catalysts made of CuMn2O4werein situprepared on Ti mesh substrate through the associated methods of plasma electrolyte oxidation and hydrothermal technique. The surface morphology, elemental distribution and chemical state, phase composition and microstructure of CuMn2O4nanostructures prepared under different conditions were systemically investigated. To evaluate the catalytic activity, the CO oxidation as a probe reaction was used, and the results showed that 12h-Cu1Mn2-300 (hydrothermal reaction at 150 °C for 12 h, Cu/Mn = 1/2 in initial precursor, heat treatment temperature at 300 °C) exhibited the best CO oxidation capability withT100= 150 °C owe to the formation of uniform CuMn2O4nanosheet layersin situgrown on flexible Ti mesh and the synergistic effect of Cu and Mn species in spinel CuMn2O4, which makes it more active towards CO oxidation than pure copper/manganese oxides.

Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment.

Currently, chemotherapy is the main treatment for tumors, but there are still problems such as unsatisfactory chemotherapy results, susceptibility to drug resistance, and serious adverse effects. Natural compounds have numerous pharmacological activities which are important sources of drug discovery for tumor treatment. The combination of chemotherapeutic drugs and natural compounds is gradually becoming an important strategy and development direction for tumor treatment. In this paper, we described the role of natural compounds in combination with chemotherapeutic drugs in synergizing, reducing drug resistance, mitigating adverse effects and related mechanisms, and providing new insights for future oncology research.

Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review.

Hepatocellular carcinoma (HCC), the most prevalent subtype of liver cancer, is the second main reason for cancer-related deaths worldwide. In recent decades, sufficient evidence supported that immunotherapy was a safe and effective treatment option for HCC. However, tolerance and frequent recurrence and metastasis occurred in patients after immunotherapy due to the complicated crosstalk in the tumor immunosuppressive microenvironment (TIME) in HCC. Therefore, elucidating the TIME in HCC and finding novel modulators to target TIME for attenuating immune suppression is critical to optimize immunotherapy. Recently, studies have shown the potentially immunoregulatory activities of natural compounds, characterized by multiple targets and pathways and low toxicity. In this review, we concluded the unique role of TIME in HCC. Moreover, we summarized evidence that supports the hypothesis of natural compounds to target TIME to improve immunotherapy. Furthermore, we discussed the comprehensive mechanisms of these natural compounds in the immunotherapy of HCC. Accordingly, we present a well-grounded review of the naturally occurring compounds in cancer immunotherapy, expecting to shed new light on discovering novel anti-HCC immunomodulatory drugs from natural sources.

Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).

Alzheimer's disease (AD) is one of the most common neurodegenerative disorders, which is characterized by the primary risk factor, age. Several attempts have been made to treat AD, while most of them end in failure. However, with the deepening study of pathogenesis of AD, the expression of HDAC6 in the hippocampus, which plays a major role of the memory formation, is becoming worth of notice. Neurofibrillary tangles (NFTs), a remarkable lesion in AD, has been characterized in association with the abnormal accumulation of hyperphosphorylated Tau, which is mainly caused by the high expression of HDAC6. On the other hand, the hypoacetylated tubulin induced by HDAC6 is also fatal for the neuronal transport, which is the key impact of the formation of axons and dendrites. Overall, the significantly increased expression of HDAC6 in brain regions is deleterious to neuron survival in AD patients. Based on the above research, the inhibition of HDAC6 seems to be a potential therapeutic method for the treatment of AD. Up to now, various types of HDAC6 inhibitors have been discovered. This review mainly analyzes the HDAC6 inhibitors reported amid 2010-2020 in terms of their structure, selectivity and pharmacological impact towards AD. And we aim at facilitating the design and development of better HDAC6 inhibitors in the future.

Insights into N, P, S multi-doped Mo2C/C composites as highly efficient hydrogen evolution reaction catalysts.

Heteroatom doping has been proved to be an effective strategy to optimize the activity of hydrogen evolution reaction (HER) catalysts. Herein, we report N, P, S multi-doped Mo2C/C composites exhibiting highly efficient HER performance in acidic solution, which are facilely fabricated via annealing of N, P, S-containing MoO x -polyaniline (MoO x -PANI) hybrid precursors. The optimized N, P, S multi-doped Mo2C/C catalyst with a moderate P dopant level (NPS-Mo2C/C-0.5) exhibits excellent performance with an overpotential of 53 mV to achieve a current density of 20 mA cm-2, a Tafel slope of 72 mV dec-1 and good stability in acidic electrolytes. Based on the study of XPS, EPR and 31P MAS NMR, the excellent electrocatalytic performance could be attributed to the effective electronic configuration modulation of both Mo2C nanorods and the carbon matrix, derived from stronger synergistic N, P, S multi-doping coupling effects. This work provides a promising methodology for the design and fabrication of multi-doped transition metal based electrocatalysts via electronic structure engineering.